BiTrial Clinical Research
BiTrial Clinical Research is a Budapest-based, privately held mid-sized Contract Research Organization providing clinical trial management and support services to pharma, biotech, medical device manufacturers, and other CROs across 18 Central-Eastern European countries.
- Company typePrivate
- Founded2002
- HeadquartersBudapest, Hungary
- Headcount11–50
- GTM typeB2B
- OfferingServices
What BiTrial Clinical Research does
BiTrial Clinical Research is a privately held, mid-sized Contract Research Organization (CRO) headquartered in Budapest, Hungary. Founded in 2002, the company delivers clinical trial management and support services to pharmaceutical, biotechnology, and medical device manufacturers, and operates as a regional sub-contractor for other global CROs. Its stated operational footprint covers 18 countries across Central-Eastern Europe and the Caucasus: Hungary, Poland, Romania, Czech Republic, Bulgaria, Slovakia, Slovenia, Croatia, Serbia, Bosnia and Herzegovina, Montenegro, North Macedonia, Austria, Moldova, Georgia, Armenia, and Azerbaijan.
The company organizes its offering around two primary service lines. Pharma R&D and Real World Evidence Studies encompasses medical writing, clinical monitoring and project management, country and site feasibility, regulatory and ethics approvals, biostatistics, data management, quality assurance, study and site start-up, and vendor management. Medical Device Studies covers regulatory planning and submissions, preclinical and laboratory studies, clinical data collection, technical documentation, conformity assessment applications, and post-market surveillance (PMS/PMCF) activities. BiTrial is certified to ISO 9001:2015 (quality management for CRO operations) and ISO 13485:2016 (quality management for medical devices), both cited as procurement-relevant differentiators.
The revenue model is professional services: custom-quoted engagements with pricing tied to study scope, duration, number of sites, and therapeutic area, with no public pricing. Distribution is direct enterprise sales to pharma sponsors, biotechs, and medical device manufacturers, supplemented by subcontracting relationships with global CROs. The publicly visible customer base is unusually concentrated among top-tier multinationals — Roche, Merck, Novartis, Janssen, Bayer, AstraZeneca, Sanofi, Boehringer Ingelheim, Novo Nordisk, AbbVie, Abbott, Medtronic on the sponsor side, and IQVIA, Syneos Health, Parexel, PPD, INC Research, Chiltern, and Synteract on the global-CRO side — along with regional operators such as Richter Gedeon, Ferring, Astellas, Baxter, Angelini, Egis, and Mundipharma. No financial metrics, headcount beyond the 51–100 band, or management team beyond the founder role are publicly disclosed.
BiTrial Clinical Research firmographics
Firmographics- Name
- BiTrial Clinical Research
- Legal name
- BiTrial Clinical Research
- Website
- https://bitrial.hu
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BiTrial Clinical Research is a Budapest-based, privately held mid-sized Contract Research Organization providing clinical trial management and support services to pharma, biotech, medical device manufacturers, and other CROs across 18 Central-Eastern European countries.
- Ownership category
- akta.pro rank
BiTrial Clinical Research industry classification
Industry- Product category
- Contract Research Organization (Clinical Trial Services)
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where BiTrial Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Budapest
- HQ country
- Hungary
- HQ region
- Europe
Offices1 record
Markets served
BiTrial Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: Provides comprehensive CRO services including clinical monitoring, project management, regulatory affairs, biostatistics, data management, and quality assurance for pharmaceutical, biotech, and medical device companies conducting clinical trials
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
BiTrial Clinical Research product offering
Product offeringCore offering
BiTrial Clinical Research is a privately owned, mid-sized Contract Research Organization (CRO) that delivers clinical trial services across 18 countries in Central-Eastern Europe for pharmaceutical, biotechnology, and medical device sponsors, as well as other CROs. Its offering spans two primary service lines — Pharma R&D and Real World Evidence Studies, and Medical Device Studies — covering medical writing, clinical monitoring, project management, site feasibility, regulatory and ethics approvals, biostatistics, data management, quality assurance, study start-up, vendor management, regulatory planning and submissions, preclinical/laboratory studies, clinical data collection, technical documentation, conformity assessment, and post-market surveillance (PMS/PMCF).
Product overview
BiTrial Clinical Research is a Contract Research Organization (CRO) providing clinical trial services across Central and Eastern Europe. The company offers two primary service lines: Pharma R&D and Real World Evidence Studies, and Medical Device Studies. The Pharma R&D service encompasses 9 sub-services including medical writing, clinical monitoring/project management, site feasibility, regulatory approvals, biostatistics/data management, quality assurance, study start-up, and vendor management. The Medical Device Studies service includes 7 sub-services covering regulatory planning, preclinical studies, clinical data collection, technical documentation, conformity assessment, and post-market surveillance (PMS/PMCF). The company operates across 18 countries in the Central-Eastern European region.
Differentiator
Problem solved
Functional benefit
Companies that use BiTrial Clinical Research
Customer profileNamed customers26 records
Segments3 records
Ideal customer profiles3 records
BiTrial Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
BiTrial Clinical Research partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor.
- AxonalminorPartner site/network member visible in logo section
- SyneorminorPartner site/network member visible in logo section
- SynteractminorCRO partner visible in logo section
- ChilternminorCRO partner visible in logo section
- ParexelminorCRO partner visible in logo section
- IQVIAminorCRO partner visible in logo section
- Syneos HealthminorCRO partner visible in logo section
- PPDminorCRO partner visible in logo section
- INC ResearchminorCRO partner visible in logo section
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
BiTrial Clinical Research competitors and assessment
Company assessmentBroad incumbents
- Parexel: Major global CRO with end-to-end clinical development services, recently taken private. BiTrial is listed as a regional CRO partner, making Parexel both a comparable incumbent and a direct channel partner.
- Charles River Laboratories: Large contract research organization with preclinical, discovery, and clinical service lines. Comparable as an established incumbent CRO serving pharma/biotech, though more weighted to early-stage and laboratory services than BiTrial's clinical-operations focus.
- Syneos Health: Large global biopharma solutions organization combining CRO and commercial services. BiTrial is a listed regional partner; Syneos represents both a comparable incumbent in clinical operations and a prime-CRO channel partner.
- ICON plc: Top-tier global CRO offering full-service clinical research with significant global footprint. Comparable in full-service clinical trial offerings but operates at materially larger scale across all major geographies.
- IQVIA: Largest global CRO with full-service clinical operations across all phases and geographies. BiTrial acts as a regional sub-CRO partner to IQVIA, and IQVIA's prime-CRO dominance directly shapes BiTrial's addressable opportunity set.
Direct peers
- Ergomed: Mid-sized full-service CRO with similar Phase I-IV clinical trial management capabilities, including pharmacovigilance and site management. Directly comparable in size, service scope, and customer mix to BiTrial, though Ergomed has broader geographic reach.
- Worldwide Clinical Trials: Mid-sized global CRO offering Phase I-IV clinical development services across multiple therapeutic areas. Comparable in mid-tier positioning and full-service clinical operations, with similar reliance on biopharma and biotech sponsors.
- PSI CRO: Privately held mid-sized CRO offering full-service clinical trial management. Closely comparable in scale, ownership structure (private/founder-influenced), and service breadth to BiTrial, with overlapping presence in European markets.
- Medpace: Mid-sized full-service CRO focused on small-to-mid biopharma sponsors with full-stack clinical trial services. Directly comparable in operating model and service breadth, though materially larger in headcount and revenue.
Regional players
- Cromos Pharma: Regional CRO with a Central-Eastern European footprint focused on full-service clinical trial management. Directly comparable as a CEE-anchored mid-sized CRO competing for similar regional trial work and subcontracted engagements.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BiTrial Clinical Research social profiles
Digital presenceBiTrial Clinical Research compliance and trust
Trust signalCompliance2 records
BiTrial Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
BiTrial Clinical Research leadership team
Management profileNumber of profiles
Profiles1 record
BiTrial Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BiTrial Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BiTrial Clinical Research
What does BiTrial Clinical Research do?
BiTrial Clinical Research is a privately owned, mid-sized Contract Research Organization (CRO) that delivers clinical trial services across 18 countries in Central-Eastern Europe for pharmaceutical, biotechnology, and medical device sponsors, as well as other CROs. Its offering spans two primary service lines — Pharma R&D and Real World Evidence Studies, and Medical Device Studies — covering medical writing, clinical monitoring, project management, site feasibility, regulatory and ethics approvals, biostatistics, data management, quality assurance, study start-up, vendor management, regulatory planning and submissions, preclinical/laboratory studies, clinical data collection, technical documentation, conformity assessment, and post-market surveillance (PMS/PMCF).
Is BiTrial Clinical Research a public or private company?
BiTrial Clinical Research is a private company. It is classified as family owned and is currently operating.
When was BiTrial Clinical Research founded?
BiTrial Clinical Research was founded in 2002. It employs 11 to 50 people.
Where is BiTrial Clinical Research based?
BiTrial Clinical Research is headquartered in Budapest, Hungary, in the Europe region.
How does BiTrial Clinical Research make money?
One revenue line is on record: clinical Research Services.
Who are BiTrial Clinical Research's main competitors?
Broad incumbents on record are Parexel, Charles River Laboratories, Syneos Health, ICON plc and IQVIA. Direct peers are Ergomed, Worldwide Clinical Trials, PSI CRO and Medpace. Cromos Pharma is listed as a regional player.
Does BiTrial Clinical Research have an API?
No public API is recorded for BiTrial Clinical Research.
What industry is BiTrial Clinical Research in?
BiTrial Clinical Research's product category is Contract Research Organization (Clinical Trial Services). Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote). Its NAICS code is 54171 and its SIC code is 8731.